Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 4
2005 5
2006 8
2007 7
2008 15
2009 17
2010 22
2011 29
2012 15
2013 27
2014 19
2015 13
2016 10
2017 13
2018 11
2019 17
2020 27
2021 28
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

256 results
Results by year
Filters applied: . Clear all
Page 1
The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres.
Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, Brodszky V, Canis M, Colombo GL, DeLeire T, Falcone T, Graham B, Halis G, Horne A, Kanj O, Kjer JJ, Kristensen J, Lebovic D, Mueller M, Vigano P, Wullschleger M, D'Hooghe T. Simoens S, et al. Hum Reprod. 2012 May;27(5):1292-9. doi: 10.1093/humrep/des073. Epub 2012 Mar 14. Hum Reprod. 2012. PMID: 22422778
Nanomedicines: The magic bullets reaching their target?
Flühmann B, Ntai I, Borchard G, Simoens S, Mühlebach S. Flühmann B, et al. Among authors: simoens s. Eur J Pharm Sci. 2019 Feb 1;128:73-80. doi: 10.1016/j.ejps.2018.11.019. Epub 2018 Nov 20. Eur J Pharm Sci. 2019. PMID: 30465818 Free article. Review.
Pharmaco-economic aspects of sipuleucel-T.
Simoens S. Simoens S. Hum Vaccin Immunother. 2012 Apr;8(4):506-8. doi: 10.4161/hv.18334. Epub 2012 Feb 16. Hum Vaccin Immunother. 2012. PMID: 22336882 Review.
Health Economics of Antibiotics.
Simoens S. Simoens S. Pharmaceuticals (Basel). 2010 Apr 29;3(5):1348-1359. doi: 10.3390/ph3051348. Pharmaceuticals (Basel). 2010. PMID: 27713306 Free PMC article. Review.
Tendering and biosimilars: what role for value-added services?
Simoens S, Cheung R. Simoens S, et al. J Mark Access Health Policy. 2019 Dec 22;8(1):1705120. doi: 10.1080/20016689.2019.1705120. eCollection 2020. J Mark Access Health Policy. 2019. PMID: 32002174 Free PMC article. Review.
Integrative Review of Managed Entry Agreements: Chances and Limitations.
Zampirolli Dias C, Godman B, Gargano LP, Azevedo PS, Garcia MM, Souza Cazarim M, Pantuzza LLN, Ribeiro-Junior NG, Pereira AL, Borin MC, de Figueiredo Zuppo I, Iunes R, Pippo T, Hauegen RC, Vassalo C, Laba TL, Simoens S, Márquez S, Gomez C, Voncina L, Selke GW, Garattini L, Kwon HY, Gulbinovic J, Lipinska A, Pomorski M, McClure L, Fürst J, Gambogi R, Ortiz CH, Canuto Santos VC, Araújo DV, Araujo VE, Acurcio FA, Alvares-Teodoro J, Guerra-Junior AA. Zampirolli Dias C, et al. Among authors: simoens s. Pharmacoeconomics. 2020 Nov;38(11):1165-1185. doi: 10.1007/s40273-020-00943-1. Pharmacoeconomics. 2020. PMID: 32734573 Review.
The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases.
Kim H, Alten R, Avedano L, Dignass A, Gomollón F, Greveson K, Halfvarson J, Irving PM, Jahnsen J, Lakatos PL, Lee J, Makri S, Parker B, Peyrin-Biroulet L, Schreiber S, Simoens S, Westhovens R, Danese S, Jeong JH. Kim H, et al. Among authors: simoens s. Drugs. 2020 Feb;80(2):99-113. doi: 10.1007/s40265-020-01256-5. Drugs. 2020. PMID: 32002851 Free PMC article. Review.
256 results